Eco R1 Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.16 Billion distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $206M, Jazz Pharmaceuticals PLC with a value of $181M, Crinetics Pharmaceuticals, Inc. with a value of $123M, I Teos Therapeutics, Inc. with a value of $107M, and Crispr Therapeutics Ag with a value of $67.6M.

Examining the 13F form we can see an decrease of $112M in the current position value, from $1.27B to 1.16B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.16 Billion
Healthcare: $1.16 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $1.16 Billion
  • Prior Value $1.27 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 6 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.